| RS2486803720 |
ANK1
|
Health Risk |
Likely pathogenic |
Hereditary spherocytosis type 1, Hereditary spherocytosis type 1 |
| RS2486806675 |
KAT6A
|
Health Risk |
Pathogenic |
— |
| RS2486806807 |
HGSNAT
|
Health Risk |
Pathogenic |
Mucopolysaccharidosis, MPS-III-C |
| RS2486807516 |
KAT6A
|
Health Risk |
Likely pathogenic |
KAT6A-related disorder, KAT6A-related disorder |
| RS2486808089 |
HGSNAT
|
Health Risk |
Pathogenic |
Retinitis pigmentosa 73, Mucopolysaccharidosis |
| RS2486808111 |
KAT6A
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS2486812921 |
KAT6A
|
Health Risk |
Likely pathogenic |
Autosomal dominant intellectual disability-craniofacial anomalies-cardiac defects syndrome, Autosomal dominant intellectual disability-craniofacial anomalies-cardiac defects syndrome |
| RS2486817571 |
ANK1
|
Health Risk |
Likely pathogenic |
ANK1-related disorder, ANK1-related disorder |
| RS2486817952 |
ANK1
|
Health Risk |
Pathogenic/Likely pathogenic |
Hereditary spherocytosis type 1, Hereditary spherocytosis type 1 |
| RS2486822374 |
KAT6A
|
Health Risk |
Likely pathogenic |
KAT6A-related disorder, KAT6A-related disorder |
| RS2486822966 |
ANK1
|
Health Risk |
Likely pathogenic |
Hereditary spherocytosis type 1, Hereditary spherocytosis type 1 |
| RS2486823524 |
ANK1
|
Health Risk |
Likely pathogenic |
Hereditary spherocytosis type 1, Hereditary spherocytosis type 1 |
| RS2486823536 |
ANK1
|
Health Risk |
Pathogenic/Likely pathogenic |
Hereditary spherocytosis type 1, Hereditary spherocytosis type 1 |
| RS2486826655 |
KAT6A
|
Health Risk |
Likely pathogenic |
Autosomal dominant intellectual disability-craniofacial anomalies-cardiac defects syndrome, Autosomal dominant intellectual disability-craniofacial anomalies-cardiac defects syndrome |
| RS2486836794 |
TEX15
|
Health Risk |
Likely pathogenic |
Spermatogenic failure 25, Spermatogenic failure 25 |
| RS2486838960 |
ANK1
|
Health Risk |
Likely pathogenic |
Hereditary spherocytosis type 1, Hereditary spherocytosis type 1 |
| RS2486839062 |
ANK1
|
Health Risk |
Likely pathogenic |
Hereditary spherocytosis type 1, Hereditary spherocytosis type 1 |
| RS2486839378 |
ANK1
|
Health Risk |
Pathogenic |
— |
| RS2486839570 |
ANK1
|
Health Risk |
Pathogenic |
— |
| RS2486842168 |
ANK1
|
Health Risk |
Likely pathogenic |
Hereditary spherocytosis type 1, Hereditary spherocytosis type 1 |
| RS2486842193 |
ANK1
|
Health Risk |
Pathogenic |
— |
| RS2486847061 |
HGSNAT
|
Health Risk |
Pathogenic |
Retinitis pigmentosa 73, Mucopolysaccharidosis |
| RS2486853907 |
ANK1
|
Health Risk |
Likely pathogenic |
Hereditary spherocytosis type 1, Hereditary spherocytosis type 1 |
| RS2486857105 |
DDHD2
|
Health Risk |
Pathogenic |
Hereditary spastic paraplegia 54, Hereditary spastic paraplegia 54 |
| RS2486869082 |
ANK1
|
Health Risk |
Pathogenic/Likely pathogenic |
Hereditary spherocytosis type 1, Hereditary spherocytosis type 1 |
| RS2486869276 |
ANK1
|
Health Risk |
Pathogenic/Likely pathogenic |
Hereditary spherocytosis type 1, Hereditary spherocytosis type 1 |
| RS2486869415 |
ANK1
|
Health Risk |
Likely pathogenic |
— |
| RS2486869462 |
ANK1
|
Health Risk |
Pathogenic |
— |
| RS2486881810 |
NEFL
|
Health Risk |
Pathogenic |
Charcot-Marie-Tooth disease type 2E, Charcot-Marie-Tooth disease type 2E |
| RS2486881927 |
NEFL
|
Health Risk |
Pathogenic |
Charcot-Marie-Tooth disease type 2E, Charcot-Marie-Tooth disease type 2E |
| RS2486883041 |
NEFL
|
Health Risk |
Likely pathogenic |
Charcot-Marie-Tooth disease type 2E, Charcot-Marie-Tooth disease type 2E |
| RS2486886091 |
NEFL
|
Health Risk |
Pathogenic |
Charcot-Marie-Tooth disease type 2E, Charcot-Marie-Tooth disease type 2E |
| RS2486886183 |
NEFL
|
Health Risk |
Pathogenic |
Charcot-Marie-Tooth disease type 2E, Charcot-Marie-Tooth disease type 2E |
| RS2486886254 |
NEFL
|
Health Risk |
Pathogenic |
Charcot-Marie-Tooth disease type 2E, Charcot-Marie-Tooth disease type 2E |
| RS2486886357 |
NEFL
|
Health Risk |
Pathogenic |
Auditory neuropathy, Auditory neuropathy |
| RS2486887879 |
NEFL
|
Health Risk |
Conflicting classifications of pathogenicity |
Charcot-Marie-Tooth disease, dominant intermediate G |
| RS2486899576 |
ANK1
|
Health Risk |
Pathogenic |
Hereditary spherocytosis type 1, Hereditary spherocytosis type 1 |
| RS2486899596 |
ANK1
|
Health Risk |
Likely pathogenic |
Hereditary spherocytosis type 1, Hereditary spherocytosis type 1 |
| RS2486899883 |
ANK1
|
Health Risk |
Likely pathogenic |
Hereditary spherocytosis type 1, Hereditary spherocytosis type 1 |
| RS2486900052 |
ANK1
|
Health Risk |
Pathogenic |
ANK1-related disorder, ANK1-related disorder |
| RS2486900565 |
LYN
|
Health Risk |
Pathogenic |
LYN kinase associated vasculopathy and liver fibrosis syndrome, Autoinflammatory disease |
| RS2486900574 |
LYN
|
Health Risk |
Pathogenic |
Autoinflammatory disease, systemic |
| RS2486900588 |
LYN
|
Health Risk |
Pathogenic |
LYN kinase associated vasculopathy and liver fibrosis syndrome, Autoinflammatory disease |
| RS2486900824 |
ANK1
|
Health Risk |
Likely pathogenic |
Hereditary spherocytosis type 1, Hereditary spherocytosis type 1 |
| RS2486904791 |
HGSNAT
|
Health Risk |
Pathogenic |
Mucopolysaccharidosis, MPS-III-C |
| RS2486907364 |
ANK1
|
Health Risk |
Likely pathogenic |
Hereditary spherocytosis type 1, Hereditary spherocytosis type 1 |
| RS2486908416 |
HGSNAT
|
Health Risk |
Pathogenic/Likely pathogenic |
HGSNAT-related disorder, Retinitis pigmentosa 73 |
| RS2486913461 |
ANK1
|
Health Risk |
Pathogenic |
Hereditary spherocytosis type 1, Hereditary spherocytosis type 1 |
| RS2486913654 |
ANK1
|
Health Risk |
Likely pathogenic |
Hereditary spherocytosis type 1, Hereditary spherocytosis type 1 |
| RS2486914036 |
ANK1
|
Health Risk |
Likely pathogenic |
Hereditary spherocytosis type 1, Hereditary spherocytosis type 1 |
| RS2486914467 |
ANK1
|
Health Risk |
Pathogenic/Likely pathogenic |
Hereditary spherocytosis type 1, Hereditary spherocytosis type 1 |
| RS2486915070 |
ANK1
|
Health Risk |
Pathogenic |
Hereditary spherocytosis type 1, Hereditary spherocytosis type 1 |
| RS2486915303 |
ANK1
|
Health Risk |
Likely pathogenic |
— |
| RS2486915489 |
ANK1
|
Health Risk |
Pathogenic/Likely pathogenic |
Hereditary spherocytosis type 1, ANK1-related disorder |
| RS2486918870 |
HGSNAT
|
Health Risk |
Pathogenic/Likely pathogenic |
Retinitis pigmentosa 73, Mucopolysaccharidosis |
| RS2486918882 |
HGSNAT
|
Health Risk |
Pathogenic |
Mucopolysaccharidosis, MPS-III-C |
| RS2486918970 |
HGSNAT
|
Health Risk |
Pathogenic/Likely pathogenic |
Retinitis pigmentosa 73, Mucopolysaccharidosis |
| RS2486919204 |
HGSNAT
|
Health Risk |
Pathogenic |
Retinitis pigmentosa 73, Mucopolysaccharidosis |
| RS2486919454 |
HGSNAT
|
Health Risk |
Pathogenic |
Mucopolysaccharidosis, MPS-III-C |
| RS2486919501 |
HGSNAT
|
Health Risk |
Likely pathogenic |
Mucopolysaccharidosis, MPS-III-C |
| RS2486922970 |
DDHD2
|
Health Risk |
Likely pathogenic |
Hereditary spastic paraplegia 54, Hereditary spastic paraplegia 54 |
| RS2486923005 |
ANK1
|
Health Risk |
Likely pathogenic |
Hereditary spherocytosis type 1, Hereditary spherocytosis type 1 |
| RS2486923028 |
ANK1
|
Health Risk |
Pathogenic |
— |
| RS2486923068 |
ANK1
|
Health Risk |
Likely pathogenic |
Hereditary spherocytosis type 1, Hereditary spherocytosis type 1 |
| RS2486923136 |
ANK1
|
Health Risk |
Pathogenic |
Hereditary spherocytosis type 1, Hereditary spherocytosis type 1 |
| RS2486928338 |
ANK1
|
Health Risk |
Pathogenic |
Hereditary spherocytosis type 1, Hereditary spherocytosis type 1 |
| RS2486933207 |
ANK1
|
Health Risk |
Pathogenic |
— |
| RS2486933563 |
ANK1
|
Health Risk |
Likely pathogenic |
Hereditary spherocytosis type 1, Hereditary spherocytosis type 1 |
| RS2486933586 |
ANK1
|
Health Risk |
Pathogenic |
— |
| RS2486943142 |
SLC20A2
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS2486943932 |
ANK1
|
Health Risk |
Pathogenic/Likely pathogenic |
Hereditary spherocytosis type 1, Hereditary spherocytosis type 1 |
| RS2486944433 |
ANK1
|
Health Risk |
Likely pathogenic |
Hereditary spherocytosis type 1, Hereditary spherocytosis type 1 |
| RS2486944833 |
ANK1
|
Health Risk |
Likely pathogenic |
Hereditary spherocytosis type 1, Hereditary spherocytosis type 1 |
| RS2486955614 |
HGSNAT
|
Health Risk |
Likely pathogenic |
Mucopolysaccharidosis, MPS-III-C |
| RS2486962491 |
HGSNAT
|
Health Risk |
Likely pathogenic |
Retinitis pigmentosa 73, Mucopolysaccharidosis |
| RS2486962842 |
ANK1
|
Health Risk |
Likely pathogenic |
— |
| RS2486962860 |
ANK1
|
Health Risk |
Likely pathogenic |
Hereditary spherocytosis type 1, Hereditary spherocytosis type 1 |
| RS2486962958 |
ANK1
|
Health Risk |
Pathogenic |
Hereditary spherocytosis type 1, Hereditary spherocytosis type 1 |
| RS2486963476 |
HGSNAT
|
Health Risk |
Pathogenic/Likely pathogenic |
Mucopolysaccharidosis, MPS-III-C |
| RS2486963515 |
ANK1
|
Health Risk |
Pathogenic |
— |
| RS2486963752 |
HGSNAT
|
Health Risk |
Likely pathogenic |
Mucopolysaccharidosis, MPS-III-C |
| RS2486963908 |
HGSNAT
|
Health Risk |
Likely pathogenic |
Mucopolysaccharidosis, MPS-III-C |
| RS2486964055 |
HGSNAT
|
Health Risk |
Likely pathogenic |
Mucopolysaccharidosis, MPS-III-C |
| RS2486966933 |
GATA4
|
Health Risk |
Pathogenic |
Atrioventricular septal defect 4, Atrioventricular septal defect 4 |
| RS2486967209 |
ANK1
|
Health Risk |
Pathogenic |
ANK1-related disorder, ANK1-related disorder |
| RS2486973322 |
HGSNAT
|
Health Risk |
Likely pathogenic |
Mucopolysaccharidosis, MPS-III-C |
| RS2486973391 |
HGSNAT
|
Health Risk |
Likely pathogenic |
Mucopolysaccharidosis, MPS-III-C |
| RS2486974458 |
GATA4
|
Health Risk |
Likely pathogenic |
Testicular anomalies with or without congenital heart disease, Atrial septal defect 2 |
| RS2486974873 |
GATA4
|
Health Risk |
Likely pathogenic |
Atrial septal defect 2, Atrial septal defect 2 |
| RS2486975023 |
GATA4
|
Health Risk |
Pathogenic |
Atrioventricular septal defect 4, Atrioventricular septal defect 4 |
| RS2486975103 |
GATA4
|
Health Risk |
Likely pathogenic |
Atrial septal defect 2, Atrial septal defect 2 |
| RS2486975242 |
GNRH1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hypogonadotropic hypogonadism, Hypogonadotropic hypogonadism |
| RS2486976242 |
ANK1
|
Health Risk |
Pathogenic |
— |
| RS2486976252 |
ANK1
|
Health Risk |
Likely pathogenic |
— |
| RS2486976664 |
ANK1
|
Health Risk |
Pathogenic |
— |
| RS2486976789 |
ANK1
|
Health Risk |
Likely pathogenic |
Hereditary spherocytosis type 1, Hereditary spherocytosis type 1 |
| RS2486980770 |
HGSNAT
|
Health Risk |
Likely pathogenic |
Mucopolysaccharidosis, MPS-III-C |
| RS2486983740 |
CASP2
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Intellectual developmental disorder |
| RS2486983838 |
CASP2
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Intellectual developmental disorder |
| RS2486983976 |
RPS20
|
Health Risk |
Pathogenic |
— |